Evaluation of the Clinical and Economic Burden of Poor Glycemic Control Associated with Therapeutic Inertia in Patients with Type 2 Diabetes in the United States
Crossref DOI link: https://doi.org/10.1007/s12325-019-01199-8
Published Online: 2020-01-10
Published Print: 2020-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ali, Sarah Naz
Dang-Tan, Tam
Valentine, William J.
Hansen, Brian Bekker
Funding for this research was provided by:
Novo Nordisk
Text and Data Mining valid from 2020-01-10
Version of Record valid from 2020-01-10
Article History
Received: 29 November 2019
First Online: 10 January 2020